Author:
Walitza Susanne,Smigielski Lukasz,Gerlach Manfred
Publisher
Springer Berlin Heidelberg
Reference253 articles.
1. AACAP Official Action (2002) Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Psy 41(Suppl 2):26S–49S
2. AACAP Official Action (2007) Practise parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Child Psy 46:894–921
3. AWMF (2018) (S3) Leitlinie „Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Kindes-, Jugend- und Erwachsenenalter“. AWMF-Register Nr. 028-045. https://www.awmf.org/leitlinien/detail/ll/028-045.html. Zugegriffen: 30. Okt. 2021
4. Ahmann PA, Theye FW, Berg R et al. (2001) Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects. Pediatrics 107:E10
5. Albin RL (2006) Neurobiology of basal ganglia and Tourette syndrome: Striatal and dopamine function. Adv Neurol 99:99–106